Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Significant Decline in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 2,485,086 shares, a drop of 21.6% from the December 15th total of 3,170,074 shares. Based on an average daily volume of 103 shares, the short-interest ratio is currently 24,127.0 days. Based on an average daily volume of 103 shares, the short-interest ratio is currently 24,127.0 days.

Vimian Group AB (publ) Stock Performance

OTCMKTS:VIMGF opened at C$2.77 on Monday. The stock’s 50 day moving average price is C$2.90 and its two-hundred day moving average price is C$3.41. Vimian Group AB has a 12-month low of C$2.77 and a 12-month high of C$4.50.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.